Elevated Platelet Count is Associated with Poor Survival After Transarterial Chemoembolization Treatment in Patients with Hepatocellular Carcinoma: A Cohort Study

BACKGROUND: Platelet count (PLT) has been proved as an essential biomarker for the survival of hepatocellular carcinoma (HCC). However, the prognostic value of PLT change (ΔPLT) is still uncertain. The aim of this study was to explore the relationship between ΔPLT and HCC survival after transarteria...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, linbin, Zhang, Yan, Zheng, Peichan, Wu, Zhixian, Wang, Xuewen, Chen, Yaying, Chen, Xiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573485/
https://www.ncbi.nlm.nih.gov/pubmed/33117753
http://dx.doi.org/10.2147/JHC.S274349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573485/
https://www.ncbi.nlm.nih.gov/pubmed/33117753
http://dx.doi.org/10.2147/JHC.S274349

Ejemplares similares